Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH) and is widely studied for its potential effects on neurotrophic signaling and cognitive-related pathways. In laboratory and preclinical research models, Semax has been associated with modulation of brain-derived neurotrophic factor (BDNF), neurotransmitter activity, and neuronal protection mechanisms, making it a compound of interest in studies involving memory, focus, and neural resilience.

This compound is intended strictly for laboratory and research purposes only. Not for human or veterinary use.